Cardinal Health (CAH) stock increased by 0.33% due to significant institutional investment activity and favorable analyst upgrades that raised target prices and buy ratings for the stock, indicating growing confidence in its future performance.

Cardinal Health (CAH) stock increased by 0

Cardinal Health (CAH) stock rose by 0.33% primarily due to increased institutional investments and positive analysts' ratings, alongside recently reported earnings that surpassed expectations.

Cardinal Health (CAH) stock rose by 0

Cardinal Health (CAH) stock fell by 1.02% likely due to a decrease in institutional holdings as reported by Mutual of America Capital Management LLC, which reduced its shares, alongside concerns about the company's recent revenue performance that did not meet consensus estimates despite beating earnings predictions.

Cardinal Health (CAH) stock fell by 1

Cardinal Health (CAH) stock declined by 1.02% as Cerity Partners LLC reduced its stake in the company by 1.1%, reflecting broader changes in institutional investor holdings amid concerns over the company’s revenue performance that fell short of analyst expectations despite beating earnings estimates.

Cardinal Health (CAH) stock declined by 1

Cardinal Health (CAH) stock rose by 0.06% due to overall positive market trends and optimism around advancements in AI and manufacturing processes, which may have indirectly boosted investor confidence in companies like Cardinal Health that are tied to those industries.

Cardinal Health, Inc. (CAH) stocks were up 0.06%, supported by a "Moderate Buy" consensus from analysts, positive earnings results, and several price target upgrades from major financial institutions. 

The stock's increase is attributed to favorable analyst recommendations and a strong earnings report that exceeded expectations, alongside a recent dividend increase that may have boosted investor confidence.

Cardinal Health, Inc

Cardinal Health (CAH) stock fell by 0.41% amid a backdrop of mixed institutional investment activities and a recent earnings report that, while beating EPS expectations, showed revenue that fell short of analyst projections. The decline could be attributed to concerns over the company's revenue performance and negative return on equity, which may have affected investor confidence.

Cardinal Health (CAH) stock fell by 0

Cardinal Health (CAH) stock declined by 1.27% last night, influenced by a slight miss in revenue expectations during its most recent earnings report, which may have raised concerns among investors despite surpassing earnings per share estimates.

Cardinal Health's stock (CAH) fell by 1.9% due to concerns over significant Medicaid cuts totaling roughly $1 trillion through 2034, which are expected to adversely affect revenues across the healthcare sector, including companies like Cardinal Health despite its diversified business model.

Cardinal Health's stock (CAH) fell by 1

Cardinal Health's (CAH) stock rose 1.64% owing to increased institutional investments, positive analyst ratings, and a recent earnings report where it exceeded EPS expectations, alongside a recently declared dividend increase.

Cardinal Health's (CAH) stock rose 1

Cardinal Health's stock (CAH) rose by 1.82% following positive earnings forecasts from Leerink Partners and several analysts upgrading their ratings and target prices for the company, reflecting strong expected earnings growth and sustained investor confidence. The increase is attributed to favorable Q1 2026 EPS estimates and overall positive market sentiment from improved ratings by multiple financial institutions.

Cardinal Health's stock (CAH) rose by 1

Cardinal Health (CAH) stock experienced a decline of 1.47% following a report that Allspring Global Investments Holdings LLC reduced its stake in the company, alongside other institutional investors modifying their holdings, which may indicate a level of investor concern or profit-taking amidst a mixed earnings report and differing analyst ratings.

Cardinal Health (CAH) stock experienced a decline of 1

Cardinal Health (CAH) stock declined by 2.14% due to a combination of mixed quarterly earnings results and market reactions to recent analyst ratings and price target adjustments, with the company reporting a slight revenue miss despite beating earnings expectations.

Cardinal Health (CAH) stock declined by 2

Cardinal Health (CAH) stock rose by 0.49% after GAMMA Investing LLC increased its stake by 28.4% and various institutional investors boosted their positions, alongside positive analyst ratings and improved quarterly earnings, which collectively indicate strong investor confidence in the company's performance and growth potential.

The article discusses Cardinal Health, Inc. (CAH), noting that its stock went down by 0.28% despite a positive outlook from Jim Cramer, who commends the company's CEO for redefining its role in the healthcare industry. The stock may have declined due to its classification as a healthcare middleman, a role that has recently drawn criticism for contributing to high healthcare costs.

The article discusses Cardinal Health, Inc

Cardinal Health (CAH) stock fell by 0.28% last night amid broader discussions about its potential and market performance, though specific reasons for the decline weren't detailed in the article.

Cardinal Health (NYSE:CAH) stock rose by 0.13% due to an increase in FY2027 earnings per share estimates from Zacks Research and positive analyst ratings adjustments, reflecting growing investor confidence in the company's financial performance.

Cardinal Health (NYSE:CAH) stock rose by 0

Cardinal Health's stock (NYSE: CAH) rose by 0.13% due to a variety of factors including an increase in institutional investment interest, a recent positive earnings report that exceeded expectations, and analysts' upgrades to the stock's ratings and price targets.

Cardinal Health's stock (NYSE: CAH) rose by 0

The article discusses recent changes in institutional investor holdings of Cardinal Health, Inc. (CAH) and its stock performance, with a slight 0.13% increase attributed to favorable analyst ratings and upgraded price targets from prominent financial institutions. 

Cardinal Health's stock went up primarily due to positive analyst ratings and elevated price targets, signaling increased investor confidence.

The article discusses recent changes in institutional investor holdings of Cardinal Health, Inc

Cardinal Health (CAH) stock increased by 0.3% due to significant investment by institutional investors and positive upgrades from analysts, enhancing market confidence in the company's prospects.

Cardinal Health (CAH) stock rose 1.54% last night, partly due to increased institutional investment and positive analyst ratings, including Wells Fargo's upgrade to "overweight" and higher price targets from multiple brokerages following the company's recent earnings report that exceeded expectations.

Cardinal Health (CAH) stock rose 1

Cardinal Health (CAH) stock increased by 0.62% due to several analysts revising their price targets upward and maintaining favorable ratings, indicating positive market sentiment and potential for growth.

Cardinal Health (CAH) stock rose by 0.62% as a result of increased institutional investor interest, with Fifth Third Bancorp and other firms raising their stakes in the company.

Cardinal Health (CAH) stock rose by 0.62% due to analysts, particularly from TD Cowen, reaffirming a Buy rating and maintaining a strong price target of $162, highlighting its potential as one of the best stocks to invest in over the past year.

Cardinal Health (CAH) stock increased by 0.62% following an upgrade from Leerink Partners, which raised their FY2025 earnings per share estimates for the company, indicating positive expectations for its financial performance.

Cardinal Health (CAH) stock rose by 4.55% following an increase in its price target by Bank of America from $165 to $170, indicating strong buy sentiments from multiple brokerages which suggest potential upside for investors.

Cardinal Health (CAH) stock rose by 4

Cardinal Health (CAH) stock saw a 0.29% increase following a report that several institutional investors, including Wedmont Private Capital, raised their stakes in the company, contributing to positive market sentiment and analyst upgrades on the stock.

Cardinal Health (CAH) stock saw a 0

Cardinal Health (CAH) stock decreased by 0.7%, despite recent boosts in institutional investments and positive earnings reports, potentially due to mixed analyst ratings and lower-than-expected revenue results in the latest quarter.

Cardinal Health (CAH) stock decreased by 0

Cardinal Health (CAH) stock fell by 0.7% possibly due to broader market trends or investor reactions, despite positive news regarding its partnership with Citius Pharmaceuticals for distribution services.

Cardinal Health (CAH) stock rose by 0.38% likely due to positive market sentiment surrounding its upcoming investor day, which CNBC's Jim Cramer highlighted as a potential catalyst for gains.

Cardinal Health (CAH) stock rose by 0.38% following an upgrade from Leerink Partners, which increased its FY2026 earnings estimates for the company, signaling positive analyst sentiment and expectations for improved profitability.

Cardinal Health (CAH) stock saw a slight increase of 0.03% after Wells Fargo upgraded it from "equal weight" to "overweight," raising its price target from $136 to $179, which suggests a potential upside of 16.09% from the current price.

Cardinal Health (CAH) stock saw a slight increase of 0

Cardinal Health (CAH) stock experienced a slight increase of 0.03% due to the growing demand for elastomeric infusion pumps, driven by the devices' speed, simplicity, and operational savings for clinicians, amid rising healthcare needs and regulations.

Cardinal Health (CAH) stock experienced a slight increase of 0

Shares of Cardinal Health, Inc. (NYSE: CAH) are up by 0.29% due to a positive analyst outlook, with an average recommendation of "Moderate Buy" from fourteen brokerages, along with recent increases in price targets from firms like UBS and Morgan Stanley, as well as significant institutional investment in the company.

Shares of Cardinal Health, Inc

Cardinal Health's stock (CAH) rose 0.56% due to its strong growth in pharmaceutical distribution and oncology drugs, allowing it to capitalize on healthcare trends and outperform competitors like UnitedHealth facing regulatory challenges.

Cardinal Health's stock (CAH) rose 0

Cardinal Health (CAH) stock rose 1.26% following an upward revision of FY2025 EPS estimates by Zacks Research, which now anticipates earnings of $8.09 per share, reflecting investor confidence in the company's financial outlook.

Cardinal Health's (CAH) stock experienced a decline of -0.53%, potentially influenced by market reactions to healthcare sector developments, including significant IPO launches in digital health that may shift investor focus.

Cardinal Health's (CAH) stock experienced a decline of -0

Cardinal Health (CAH) stock fell by 0.94% following a mixed earnings report where it beat EPS estimates but fell short on revenue, alongside increased buying by Representative Marjorie Taylor Greene, indicating potential volatility and mixed investor sentiment.

Cardinal Health (CAH) stock rose 1.65% as analysts maintain a "Moderate Buy" rating with increased price targets following stronger-than-expected earnings results that exceeded consensus estimates.

Cardinal Health (CAH) stock rose by 2.75% following an upgrade by UBS Group, which increased its target price from $150.00 to $160.00 while maintaining a buy rating, along with several other analysts adjusting their price targets and ratings positively.

Cardinal Health (CAH) stock rose by 2

Shares of Cardinal Health, Inc. (CAH) rose 1.04% after UBS Group raised its price target for the stock from $150.00 to $160.00, reflecting strong buy sentiment from analysts and high trading volume. The increase in stock price is attributed to positive analyst ratings and price target upgrades from multiple firms, signaling confidence in Cardinal Health’s performance and potential for future growth.

Cardinal Health, Inc. (NYSE: CAH) saw a 0.26% increase in stock value due to Jim Cramer’s endorsement of the company on his show, suggesting it will benefit from potential disruptions in the pharmaceutical supply chain under the Trump administration.

Cardinal Health's stock (CAH) declined by 1.2%, despite having a consensus rating of "Moderate Buy" among analysts, potentially due to overall market fluctuations or investor sentiment, rather than specific negative news regarding the company itself.

Cardinal Health's stock (CAH) declined by 1

Cardinal Health (CAH) stock dropped by 5.44% following a downgrade in Q3 2025 earnings estimates by Leerink Partners, which revised the expected earnings per share down from $2.18 to $2.16.

Cardinal Health (CAH) stock dropped by 5

Cardinal Health's stock (CAH) rose by 1.12% after Mizuho increased its price target from $142.00 to $150.00, maintaining an outperform rating, which reflects growing analyst confidence in the company.

Cardinal Health (CAH) stock rose by 1.12% following an upgrade in its price target from Mizuho, which increased from $142.00 to $150.00, indicating positive analyst sentiment towards the stock's performance.

Cardinal Health (CAH) stock rose by 1

Cardinal Health's stock (CAH) decreased by 0.44% amid mixed analyst ratings and recent adjustments in price targets by major financial firms, despite an overall recommendation of "Moderate Buy" from analysts. 

The stock decline could be attributed to market volatility and investor sentiment despite positive earnings reports and upgrades from analysts.

Cardinal Health's stock (CAH) decreased by 0

The article discusses the upcoming Annual General Meeting of Bavarian Nordic A/S, highlighting proposed resolutions regarding profit application, board member re-elections, and plans for share capital increase. 

As for Cardinal Health (CAH) stock rising by 2.14%, it is likely due to positive investor sentiment regarding the company's ongoing initiatives or financial performance, which may not be detailed in the provided text.

The article discusses the upcoming Annual General Meeting of Bavarian Nordic A/S, highlighting propo

Cardinal Health (CAH) stock rose by 0.19% after Atria Investments significantly increased its holdings in the company by 22.9%, indicating strong institutional confidence, along with other hedge funds also boosting their positions in the stock.

Cardinal Health (CAH) stock rose 0.2% following an upward revision in EPS estimates for FY2025 by Zacks Research, which increased its forecast from $7.75 to $7.88 per share, indicating positive earnings expectations.

Headline	Summary	Source
Cardinal Health (CAH) stock increased by 0	Cardinal Health (CAH) stock increased by 0.33% due to significant institutional investment activity and favorable analyst upgrades that raised target prices and buy ratings for the stock, indicating growing confidence in its future performance.	ETF Daily News
Cardinal Health (CAH) stock rose by 0	Cardinal Health (CAH) stock rose by 0.33% primarily due to increased institutional investments and positive analysts' ratings, alongside recently reported earnings that surpassed expectations.	ETF Daily News

CAH

Latest News & Analysis